Gold nanoparticles have gained significant attention in nanomedicine due to their unique physicochemical properties, including nanoscale size, optical activity, chemical stability, biocompatibility, and ease of surface functionalization. This study focuses on the synthesis and characterization of gold nanoparticles for their potential application in targeted drug delivery. Gold nanoparticles can be synthesized through a chemical reduction method using a gold precursor and suitable reducing or stabilizing agents to obtain stable colloidal nanoparticles. Their surface can be further modified with drugs, polymers, peptides, antibodies, or targeting ligands to enhance selective delivery to specific cells or tissues.
Characterization of the synthesized nanoparticles is essential to evaluate their size, morphology, surface charge, stability, functional groups, and crystalline nature. Analytical techniques such as UV-Visible spectroscopy, dynamic light scattering, zeta potential analysis, transmission electron microscopy, Fourier-transform infrared spectroscopy, and X-ray diffraction help confirm nanoparticle formation and assess their suitability as nanocarriers. The targeted delivery approach using gold nanoparticles may improve drug accumulation at the disease site, reduce systemic toxicity, and enhance therapeutic efficiency. Overall, gold nanoparticles represent a promising platform for controlled and targeted drug delivery applications, particularly in cancer therapy and other biomedical fields.
Nanotechnology has become an important area of research in biomedical science because it allows the development of materials with unique properties at the nanoscale. Among different types of nanoparticles, gold nanoparticles have gained major attention due to their excellent physicochemical and biological properties. Gold nanoparticles are known for their small size, large surface-area-to-volume ratio, optical activity, chemical stability, biocompatibility, and easy surface functionalization. These features make them highly useful in drug delivery, imaging, diagnostics, biosensing, and cancer therapy.
Targeted drug delivery is a modern therapeutic approach designed to deliver drugs directly to specific diseased cells or tissues while reducing unwanted effects on healthy cells. Conventional drug delivery systems often face several limitations, including poor drug solubility, low bioavailability, rapid degradation, non-specific distribution, and systemic toxicity. Gold nanoparticles can help overcome these limitations by acting as efficient nanocarriers for therapeutic agents. Their surfaces can be modified with drugs, polymers, peptides, antibodies, folic acid, or other targeting ligands, which help improve selective binding to target cells. This is especially important in cancer treatment, where many tumor cells overexpress specific receptors that can be recognized by functionalized nanoparticles.
The synthesis of gold nanoparticles is commonly performed using chemical reduction methods. In this process, a gold salt precursor, such as chloroauric acid, is reduced by a suitable reducing agent in the presence of a stabilizing agent to form stable colloidal gold nanoparticles. The properties of the synthesized nanoparticles, including size, shape, surface charge, and stability, are strongly influenced by experimental conditions such as precursor concentration, reducing agent concentration, pH, temperature, reaction time, and stirring speed. Therefore, careful control and optimization of the synthesis process are essential for producing nanoparticles suitable for biomedical applications.
Characterization of gold nanoparticles is a crucial step to confirm their formation and evaluate their potential for targeted drug delivery. Techniques such as UV-Visible spectroscopy, dynamic light scattering, zeta potential analysis, transmission electron microscopy, Fourier-transform infrared spectroscopy, and X-ray diffraction are commonly used to study nanoparticle size, morphology, stability, surface charge, functional groups, and crystalline nature. Proper characterization helps determine whether the synthesized nanoparticles have the required properties for drug loading, targeting, and controlled release. Overall, gold nanoparticles represent a promising platform for targeted drug delivery, offering potential advantages in improving therapeutic efficiency, reducing side effects, and supporting advanced biomedical applications.
Prepare a 1 mM chloroauric acid solution by dissolving HAuCl₄·3H2O in ultrapure water.
Heat 100 mL of 1 mM HAuCl₄ solution to boiling (100°C) with vigorous stirring.
Rapidly add 10 mL of 38.8 mM trisodium citrate solution to the boiling HAuCl₄ solution while maintaining vigorous stirring.
Continue boiling and stirring for 10 minutes after citrate addition.
Remove from heat and allow to cool to room temperature while continuing to stir.
Store the AuNP suspension at 4°C in the dark. The suspension is stable for several months under these conditions.
Size Control Mechanisms
The size of AuNPs synthesized using the Turkevich method is primarily controlled by the citrate-to-gold ratio and reaction temperature. Higher citrate concentrations generally produce smaller particles due to faster nucleation kinetics. Our optimized protocol yields particles in the 15-20 nm range, which is ideal for passive tumor targeting via the enhanced permeability and retention (EPR) effect.
Characterization Findings
UV-Vis spectroscopy reveals a characteristic surface plasmon resonance peak at approximately 520 nm, confirming the formation of spherical gold nanoparticles. The peak position and width provide insights into particle size and dispersion. DLS measurements indicate a hydrodynamic diameter of 18 ± 2 nm with a polydispersity index (PDI) of 0.15, demonstrating excellent monodispersity. TEM images confirm the spherical morphology and allow for direct measurement of core particle size.
Stability Considerations
Citrate-stabilized AuNPs exhibit good colloidal stability at neutral pH due to electrostatic repulsion. However, stability may decrease in high ionic strength solutions or at extreme pH values. For long-term storage, keep AuNP suspensions at 4°C in the dark. Do not freeze, as this may cause irreversible aggregation.
Functionalization Potential
The citrate coating on AuNPs can be readily displaced by thiols, allowing for surface modification with targeting peptides, antibodies, or other biomolecules. This enables the development of targeted drug delivery systems with enhanced specificity for diseased tissues.
This protocol provides a reliable method for synthesizing monodisperse gold nanoparticles suitable for biomedical applications. The Turkevich method offers excellent reproducibility and scalability, making it accessible to researchers across various disciplines. The resulting AuNPs exhibit uniform size distribution, good colloidal stability, and potential for surface functionalization.
Key advantages of this protocol include: (1) simplicity and minimal equipment requirements, (2) high reproducibility with proper temperature control, (3) production of biocompatible, citrate-stabilized nanoparticles, and (4) versatility for subsequent functionalization steps.
Future directions include optimizing the protocol for different size ranges, exploring alternative stabilizing agents, and developing one-pot synthesis methods that incorporate drug loading during nanoparticle formation.
The authors thank Dr. Sarah Johnson for helpful discussions on nanoparticle characterization and the Nanomaterials Characterization Facility for providing access to TEM instrumentation.